← Leaderboards
Gregory Parks Owens
University Of Colorado Denver
$1,946,562
Attributed
$2,566,423
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $406.8K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,566,423 · 3
By mechanism
R01$2,138,798 · 2
R21$427,625 · 1
Top collaborators
- Jeffrey L Bennett2 shared
- Ethan Garrett Hughes2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Donald Gilden$19,848,267
- Wendy B Macklin$14,857,442
- Mark P Burgoon$3,107,119
- Jeffrey L Bennett$6,992,785
- Kristine A. Kuhn$4,737,113
Others in their field
Top investigators on “Recombinants”
- David Heimbrook · Leidos Biomedical Research, Inc.$147,165,789
- Barton F Haynes · Duke University$134,153,827
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Stanley B Prusiner · University Of California San Francisco$55,441,768
- Thomas William Geisbert · Boston University Medical Campus$50,907,172
- Larry Arthur$46,063,806
Research focus
RecombinantsB-LymphocytesMultiple SclerosisRecombinant AntibodyImmunoglobulin GMyelinInflammatoryMediatingOligodendrogliaPathologyRelapseResponseDemyelinationsPathogenesisAntibodiesBrainAntibody FormationIn VivoAntigen TargetingAntigensImmunoassayGlycolipidsCell DeathGalactosylceramides
Grant awards (9)
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis$406,815
R01 · FY2025 · NS
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis$405,282
R01 · FY2024 · NS
Oligodendrocytes and their Precursors in a Novel Model of Antibody-Mediated Cortical Demyelination$194,375
R21 · FY2019 · NS
Oligodendrocytes and their Precursors in a Novel Model of Antibody-Mediated Cortical Demyelination$233,250
R21 · FY2018 · NS
The Role of Intrathecal Plasma Cell Clones in MS Pathogenesis$267,750
R01 · FY2015 · NS · contact PI
The Role of Intrathecal Plasma Cell Clones in MS Pathogenesis$265,072
R01 · FY2014 · NS · contact PI
The Role of Intrathecal Plasma Cell Clones in MS Pathogenesis$258,379
R01 · FY2013 · NS · contact PI
The Role of Intrathecal Plasma Cell Clones in MS Pathogenesis$267,750
R01 · FY2012 · NS · contact PI
The Role of Intrathecal Plasma Cell Clones in MS Pathogenesis$267,750
R01 · FY2011 · NS · contact PI